ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 129 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 162 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 162 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 162 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 162 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 162 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 162 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 162 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | – | 162 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 162 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | – | 162 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 162 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 162 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -85.7% | 162 | -86.1% | 0.00% | -100.0% |
| Q3 2017 | $7,000 | +600.0% | 1,162 | +617.3% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 162 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 162 | -20.2% | 0.00% | – |
| Q3 2016 | $1,000 | – | 203 | +395.1% | 0.00% | – |
| Q2 2016 | $0 | – | 41 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 41 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 15,151,516 | $38,182,000 | 7.99% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 10,406,850 | $26,225,000 | 4.02% |
| MILLER VALUE PARTNERS, LLC | 12,385,586 | $31,211,000 | 1.12% |
| CHIRON CAPITAL MANAGEMENT, LLC | 201,470 | $508,000 | 0.41% |
| Sargent Investment Group, LLC | 289,025 | $728,000 | 0.26% |
| MAGNOLIA CAPITAL ADVISORS LLC | 80,542 | $404,000 | 0.16% |
| XTX MARKETS LLC | 11,086 | $28,000 | 0.14% |
| Virtus ETF Advisers LLC | 99,108 | $250,000 | 0.13% |
| Old West Investment Management, LLC | 210,226 | $529,000 | 0.12% |
| EQUITEC PROPRIETARY MARKETS, LLC | 31,300 | $79,000 | 0.06% |